Publications - Erika D . Driver-Dunckley, M.D.

Back to Research Profile

1. Driver-Dunckley E, Connor D, Hentz J, Sabbagh M, Silverberg N, Hernandez J, Vedders L, Evidente VG, Shill H, Caviness J, Adler C. No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome. Mov Disord 2009 Sep 15; 24(12):1840-2.
   View PubMed
2. Stonnington CM, Driver-Dunckley E, Noe KH, Locke DEC. Conversion and somatization disorders. BMJ Best Practice 2009 accessible on epocrates.com. Available at: www.bestpractice.bmj.com 2009 Sep.
   View PubMed
3. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stem MB, Voon V. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009 Jul 30; 24(10):1461-7.
   View PubMed
4. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009 Jul 30; 24(10):1461-7.
   View PubMed
5. Almaraz AC, Driver-Dunckley ED, Woodruff BK, Wellik KE, Caselli RJ, Demaerschalk BM, Adler CH, Caviness JN, Wingerchuk DM. Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. Neurologist 2009 Jul; 15(4):234-7.
   View PubMed
6. Alvarez MV, Driver-Dunckley EE, Caviness JN, Adler CH, Evidente VG. Case series of painful legs and moving toes: clinical and electrophysiologic observations. Mov Disord 2008 Oct 30; 23(14):2062-6.
   View PubMed
7. Alvarez MV, Driver-Dunckley EE, Caviness JN, Adler CH, Evidente VGH. Case series of painful legs and moving toes: clinical and electrophysiologic observations. Movement Disorders 2008 Aug 29. [Epub ahead of print]
   View PubMed
8. Goodman BP, Driver-Dunckley ED, Leslie KO, Patel AC, Wesselius LJ. A case of gait unsteadiness--an atypical manifestation of an unusual disease. Lancet Neurol 2007 Nov; 6(11):1029-32.
   View PubMed
9. Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007 Sep-Oct; 30(5):249-55.
   View PubMed
10. Alvarez MV, Evidente VG, Driver-Dunckley ED. Differentiating Parkinson's disease from other parkinsonian disorders. Semin Neurol 2007 Sep; 27(4):356-62.
    View PubMed
11. Alvarez MV, Evidente VGH, Driver-Dunckley ED. Differentiating Parkinson's disease from other Parkinsonian disorders. Seminars in Neurology. 2007 Sep; 27(4):356.
    View PubMed
12. Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH. Gambling and increased sexual desire with dopaminergic medications in restless leg syndrome. Clin Neuropharmacol 2007 Sep/Oct; 30(5):249-255.
    View PubMed
13. Caviness JN, Hentz JG, Evidente VG, Driver-Dunckley E, Samanta J, Mahant P, Connor DJ, Sabbagh MN, Shill HA, Adler CH. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord 2007 Aug; 13(6):348-54. Epub 2007 Mar 08.
    View PubMed
14. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007 Jul 15; 22(9):1272-7.
    View PubMed
15. Sabbagh MN, Lahti T, Connor DJ, Caviness JN, Shill H, Vedders L, Mahant P, Samanta J, Burns RS, Evidente VG, Driver-Dunckley E, Reisberg B, Bircea S, Adler CH. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24(5):327-34. Epub 2007 Sep 13.
    View PubMed
16. Driver-Dunckley E, Evidente VG, Adler CH, Hillman R, Hernandez J, Fletcher G, Lyons MK. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord 2006 Aug; 21(8):1287-9.
    View PubMed
17. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003 Aug 12; 61(3):422-3.
    View PubMed
18. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994 Aug 11; 22(15):3181-6.
    View PubMed